NDC 72934-5143

METRONIDAZOLE 1% / MUPIROCIN 2%

Metronidazole 1% / Mupirocin 2%

METRONIDAZOLE 1% / MUPIROCIN 2% is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Metronidazole; Mupirocin.

Product ID72934-5143_88de7b4e-89f3-7b7d-e053-2a95a90a70b2
NDC72934-5143
Product TypeHuman Prescription Drug
Proprietary NameMETRONIDAZOLE 1% / MUPIROCIN 2%
Generic NameMetronidazole 1% / Mupirocin 2%
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2019-05-15
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameMETRONIDAZOLE; MUPIROCIN
Active Ingredient Strength1 g/100g; g/100g
Pharm ClassesNitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS],RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-5143-2

30 g in 1 BOTTLE, PUMP (72934-5143-2)
Marketing Start Date2019-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-5143-2 [72934514302]

METRONIDAZOLE 1% / MUPIROCIN 2% OINTMENT
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-15

Drug Details

Active Ingredients

IngredientStrength
METRONIDAZOLE1 g/100g

OpenFDA Data

SPL SET ID:88de7b4e-89f2-7b7d-e053-2a95a90a70b2
Manufacturer
UNII

Pharmacological Class

  • Nitroimidazole Antimicrobial [EPC]
  • Nitroimidazoles [CS]
  • RNA Synthetase Inhibitor Antibacterial [EPC]
  • RNA Synthetase Inhibitors [MoA]
  • Nitroimidazole Antimicrobial [EPC]
  • Nitroimidazoles [CS]
  • RNA Synthetase Inhibitor Antibacterial [EPC]
  • RNA Synthetase Inhibitors [MoA]

NDC Crossover Matching brand name "METRONIDAZOLE 1% / MUPIROCIN 2%" or generic name "Metronidazole 1% / Mupirocin 2%"

NDCBrand NameGeneric Name
72934-5143METRONIDAZOLE 1% / MUPIROCIN 2%METRONIDAZOLE 1% / MUPIROCIN 2%
72934-5144METRONIDAZOLE 1% / MUPIROCIN 2%METRONIDAZOLE 1% / MUPIROCIN 2%

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.